EPZICOM - abacavir sulfate and lamivudine
Navigation: NDC > Supplier starting with: S > STATE OF FLORIDA DOH CENTRAL PHARMACY| Field | Value |
|---|---|
| NDC Code: | 53808-0767 |
| Proprietary Name: | EPZICOM |
| Suffix: | |
| Non-Proprietary Name: | abacavir sulfate and lamivudine |
| Dosage Form: | TABLET, FILM COATED |
| Method: | ORAL |
| Original Marketing Date: | 01-07-2009 |
| Category Name: | NDA |
| Application Number: | NDA021652 |
| Labeler: | STATE OF FLORIDA DOH CENTRAL PHARMACY |
| Substance Name: | ABACAVIR SULFATE; LAMIVUDINE |
| Active Numerator Strength: | 600; 300 |
| Active Ingredient Unit: | mg/1; mg/1 |
| Pharm Classes: | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA],Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] |
| DEA Schedule: |